File Download
 
Links for fulltext
(May Require Subscription)
 
Supplementary

Article: Prevalence of silent kidney disease in Hong Kong: the screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program.
  • Basic View
  • Metadata View
  • XML View
TitlePrevalence of silent kidney disease in Hong Kong: the screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program.
 
AuthorsLi, PK1
Kwan, BC1
Leung, CB1
Kwan, TH1
Wong, KM1
Lui, SL1
Tsang, WK1
Mak, CC1
Mak, SK1
Yu, AW1
Tang, S1
 
Issue Date2005
 
CitationKidney International. Supplement, 2005 n. 94, p. S36-40 [How to Cite?]
 
AbstractBACKGROUND: End-stage renal disease (ESRD) is epidemic worldwide. In Hong Kong, the annual incidence of ESRD has risen from 100 pmp (per million population) in 1996 to 140 pmp in 2003. SHARE (Screening for Hong Kong Asymptomatic Renal Population and Evaluation program) is a population-based screening program aimed at identifying the prevalence of unrecognized renal disease in asymptomatic individuals, allowing further evaluation and disease-modifying interventions. METHODS: From November to December 2003, SHARE was conducted in several large residential communities in Hong Kong. The screening tool included a questionnaire documenting demographics and history or family history of diabetes mellitus (DM), hypertension (HT), and chronic kidney disease (CKD), together with on-site measurements of blood pressure (BP) and urine dipstick for protein, blood, and glucose. RESULTS: There were a total of 1811 participants. One thousand two hundred and one subjects were entered into the final analysis. Among the 1201 who were apparently "healthy" (asymptomatic and without history of DM, HT, or CKD), the prevalence of positive (> or =1+) urine dipstick for protein, glucose, blood, protein or blood, any urine abnormality, and HT (BP> or =140/90) was 3.2%, 1.7%, 13.8%, 16%, 17.4%, and 8.7%, respectively. Thirty three percent of the age over 60 years old group had either hypertension or urine abnormalities, compared with 24.0% in the 41- to 60-year-old group and 9.7% in the 20- to 40-year-old group. Having a family history of diabetes or hypertension increases the risk of having urine abnormalities, while a family history of hypertension also increases the risk of high blood pressure. CONCLUSION: It is concluded that subclinical abnormalities in urinalysis or BP readings are prevalent across all age groups in the adult population. An effective screening program at the primary care level that identifies these subjects for further evaluation is warranted, and the public in Hong Kong should be educated toward the significance of such findings in order to have regular health check for asymptomatic renal diseases.
 
ISSN0098-6577
2012 SCImago Journal Rankings: 0.669
 
DC FieldValue
dc.contributor.authorLi, PK
 
dc.contributor.authorKwan, BC
 
dc.contributor.authorLeung, CB
 
dc.contributor.authorKwan, TH
 
dc.contributor.authorWong, KM
 
dc.contributor.authorLui, SL
 
dc.contributor.authorTsang, WK
 
dc.contributor.authorMak, CC
 
dc.contributor.authorMak, SK
 
dc.contributor.authorYu, AW
 
dc.contributor.authorTang, S
 
dc.date.accessioned2012-09-05T05:23:46Z
 
dc.date.available2012-09-05T05:23:46Z
 
dc.date.issued2005
 
dc.description.abstractBACKGROUND: End-stage renal disease (ESRD) is epidemic worldwide. In Hong Kong, the annual incidence of ESRD has risen from 100 pmp (per million population) in 1996 to 140 pmp in 2003. SHARE (Screening for Hong Kong Asymptomatic Renal Population and Evaluation program) is a population-based screening program aimed at identifying the prevalence of unrecognized renal disease in asymptomatic individuals, allowing further evaluation and disease-modifying interventions. METHODS: From November to December 2003, SHARE was conducted in several large residential communities in Hong Kong. The screening tool included a questionnaire documenting demographics and history or family history of diabetes mellitus (DM), hypertension (HT), and chronic kidney disease (CKD), together with on-site measurements of blood pressure (BP) and urine dipstick for protein, blood, and glucose. RESULTS: There were a total of 1811 participants. One thousand two hundred and one subjects were entered into the final analysis. Among the 1201 who were apparently "healthy" (asymptomatic and without history of DM, HT, or CKD), the prevalence of positive (> or =1+) urine dipstick for protein, glucose, blood, protein or blood, any urine abnormality, and HT (BP> or =140/90) was 3.2%, 1.7%, 13.8%, 16%, 17.4%, and 8.7%, respectively. Thirty three percent of the age over 60 years old group had either hypertension or urine abnormalities, compared with 24.0% in the 41- to 60-year-old group and 9.7% in the 20- to 40-year-old group. Having a family history of diabetes or hypertension increases the risk of having urine abnormalities, while a family history of hypertension also increases the risk of high blood pressure. CONCLUSION: It is concluded that subclinical abnormalities in urinalysis or BP readings are prevalent across all age groups in the adult population. An effective screening program at the primary care level that identifies these subjects for further evaluation is warranted, and the public in Hong Kong should be educated toward the significance of such findings in order to have regular health check for asymptomatic renal diseases.
 
dc.description.natureLink_to_subscribed_fulltext
 
dc.identifier.citationKidney International. Supplement, 2005 n. 94, p. S36-40 [How to Cite?]
 
dc.identifier.epage40
 
dc.identifier.issn0098-6577
2012 SCImago Journal Rankings: 0.669
 
dc.identifier.issue94
 
dc.identifier.pmid15752237
 
dc.identifier.scopuseid_2-s2.0-15944403516
 
dc.identifier.spageS36
 
dc.identifier.urihttp://hdl.handle.net/10722/162803
 
dc.languageeng
 
dc.publisher.placeUnited States
 
dc.relation.ispartofKidney international. Supplement
 
dc.subject.meshAdult
 
dc.subject.meshAged
 
dc.subject.meshAged, 80 And Over
 
dc.subject.meshDiabetes Mellitus - Epidemiology
 
dc.subject.meshFemale
 
dc.subject.meshFollow-Up Studies
 
dc.subject.meshHong Kong - Epidemiology
 
dc.subject.meshHumans
 
dc.subject.meshHypertension, Renal - Epidemiology
 
dc.subject.meshKidney Diseases - Diagnosis - Epidemiology
 
dc.subject.meshMale
 
dc.subject.meshMass Screening
 
dc.subject.meshMiddle Aged
 
dc.subject.meshPrevalence
 
dc.subject.meshRisk Factors
 
dc.titlePrevalence of silent kidney disease in Hong Kong: the screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program.
 
dc.typeArticle
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Li, PK</contributor.author>
<contributor.author>Kwan, BC</contributor.author>
<contributor.author>Leung, CB</contributor.author>
<contributor.author>Kwan, TH</contributor.author>
<contributor.author>Wong, KM</contributor.author>
<contributor.author>Lui, SL</contributor.author>
<contributor.author>Tsang, WK</contributor.author>
<contributor.author>Mak, CC</contributor.author>
<contributor.author>Mak, SK</contributor.author>
<contributor.author>Yu, AW</contributor.author>
<contributor.author>Tang, S</contributor.author>
<date.accessioned>2012-09-05T05:23:46Z</date.accessioned>
<date.available>2012-09-05T05:23:46Z</date.available>
<date.issued>2005</date.issued>
<identifier.citation>Kidney International. Supplement, 2005 n. 94, p. S36-40</identifier.citation>
<identifier.issn>0098-6577</identifier.issn>
<identifier.uri>http://hdl.handle.net/10722/162803</identifier.uri>
<description.abstract>BACKGROUND: End-stage renal disease (ESRD) is epidemic worldwide. In Hong Kong, the annual incidence of ESRD has risen from 100 pmp (per million population) in 1996 to 140 pmp in 2003. SHARE (Screening for Hong Kong Asymptomatic Renal Population and Evaluation program) is a population-based screening program aimed at identifying the prevalence of unrecognized renal disease in asymptomatic individuals, allowing further evaluation and disease-modifying interventions. METHODS: From November to December 2003, SHARE was conducted in several large residential communities in Hong Kong. The screening tool included a questionnaire documenting demographics and history or family history of diabetes mellitus (DM), hypertension (HT), and chronic kidney disease (CKD), together with on-site measurements of blood pressure (BP) and urine dipstick for protein, blood, and glucose. RESULTS: There were a total of 1811 participants. One thousand two hundred and one subjects were entered into the final analysis. Among the 1201 who were apparently &quot;healthy&quot; (asymptomatic and without history of DM, HT, or CKD), the prevalence of positive (&gt; or =1+) urine dipstick for protein, glucose, blood, protein or blood, any urine abnormality, and HT (BP&gt; or =140/90) was 3.2%, 1.7%, 13.8%, 16%, 17.4%, and 8.7%, respectively. Thirty three percent of the age over 60 years old group had either hypertension or urine abnormalities, compared with 24.0% in the 41- to 60-year-old group and 9.7% in the 20- to 40-year-old group. Having a family history of diabetes or hypertension increases the risk of having urine abnormalities, while a family history of hypertension also increases the risk of high blood pressure. CONCLUSION: It is concluded that subclinical abnormalities in urinalysis or BP readings are prevalent across all age groups in the adult population. An effective screening program at the primary care level that identifies these subjects for further evaluation is warranted, and the public in Hong Kong should be educated toward the significance of such findings in order to have regular health check for asymptomatic renal diseases.</description.abstract>
<language>eng</language>
<relation.ispartof>Kidney international. Supplement</relation.ispartof>
<subject.mesh>Adult</subject.mesh>
<subject.mesh>Aged</subject.mesh>
<subject.mesh>Aged, 80 And Over</subject.mesh>
<subject.mesh>Diabetes Mellitus - Epidemiology</subject.mesh>
<subject.mesh>Female</subject.mesh>
<subject.mesh>Follow-Up Studies</subject.mesh>
<subject.mesh>Hong Kong - Epidemiology</subject.mesh>
<subject.mesh>Humans</subject.mesh>
<subject.mesh>Hypertension, Renal - Epidemiology</subject.mesh>
<subject.mesh>Kidney Diseases - Diagnosis - Epidemiology</subject.mesh>
<subject.mesh>Male</subject.mesh>
<subject.mesh>Mass Screening</subject.mesh>
<subject.mesh>Middle Aged</subject.mesh>
<subject.mesh>Prevalence</subject.mesh>
<subject.mesh>Risk Factors</subject.mesh>
<title>Prevalence of silent kidney disease in Hong Kong: the screening for Hong Kong Asymptomatic Renal Population and Evaluation (SHARE) program.</title>
<type>Article</type>
<description.nature>Link_to_subscribed_fulltext</description.nature>
<identifier.pmid>15752237</identifier.pmid>
<identifier.scopus>eid_2-s2.0-15944403516</identifier.scopus>
<identifier.issue>94</identifier.issue>
<identifier.spage>S36</identifier.spage>
<identifier.epage>40</identifier.epage>
<publisher.place>United States</publisher.place>
</item>
Author Affiliations
  1. Prince of Wales Hospital Hong Kong